• Home
  • News
  • U.S. Weightlifting Athlete Christian Buckley Accepts Sanction for Anti-Doping Rule Violation

U.S. Weightlifting Athlete Christian Buckley Accepts Sanction for Anti-Doping Rule Violation

USADA Logo

USADA announced today that Christian Buckley, of Frankfort, Ky., an athlete in the sport of weightlifting, has accepted a three-year suspension for an anti-doping rule violation.

Buckley, 24, tested positive for ostarine (enobosarm) as the result of a sample collected in competition at the Junior and U25 Nationals on June 30, 2021. Ostarine is a Non-Specified Substance in the class of Anabolic Agents and it is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the International Weightlifting Federation Anti-Doping Rules, all of which have adopted the World Anti-Doping Code (Code) and the World Anti-Doping Agency Prohibited List.

Under Article 10.8.1 of the 2021 Code, an athlete who faces an anti-doping rule violation that carries a period of ineligibility of four or more years may receive a one-year sanction reduction if the athlete admits the violation and accepts the asserted sanction within 20 days of notification of the alleged anti-doping rule violation charge. Per the rule, Buckley qualified for a one-year reduction to the otherwise applicable four-year period of ineligibility.

Buckley’s three-year period of ineligibility began on August 3, 2021, the date his provisional suspension was imposed. In addition, Buckley has been disqualified from all competitive results obtained on and subsequent to June 30, 2021, the date his positive sample was collected, including forfeiture of any medals, points and prizes.

In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.

In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a supplement guide, a nutrition guide, an athlete handbook, and periodic alerts and advisories.

USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at This email address is being protected from spambots. You need JavaScript enabled to view it., by phone at 1-877-Play Clean (1-877-752-9253) or by mail.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

The original article can be found here.

Leave a comment

Please login to leave a comment.

Courses

Legal Advisors

Upcoming Events

There are no up-coming events

Copyright © LawInSport Limited 2010 - 2021. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.